We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Seeking Clues to Cencora (COR) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
Read MoreHide Full Article
Wall Street analysts expect Cencora (COR - Free Report) to post quarterly earnings of $4.81 per share in its upcoming report, which indicates a year-over-year increase of 8.8%. Revenues are expected to be $80.76 billion, up 7% from the year-ago quarter.
The consensus EPS estimate for the quarter has been revised 0.3% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
That said, let's delve into the average estimates of some Cencora metrics that Wall Street analysts commonly model and monitor.
Analysts expect 'Revenue- Total U.S. Healthcare Solutions' to come in at $71.73 billion. The estimate suggests a change of +5.1% year over year.
Analysts predict that the 'Revenue- Total International Healthcare Solutions' will reach $7.25 billion. The estimate suggests a change of +1.1% year over year.
Analysts forecast 'Operating income- International Healthcare Solutions' to reach $171.94 million. The estimate compares to the year-ago value of $159.30 million.
The combined assessment of analysts suggests that 'Operating income- U.S. Healthcare Solutions' will likely reach $1.04 billion. Compared to the current estimate, the company reported $1.03 billion in the same quarter of the previous year.
Cencora shares have witnessed a change of -5.2% in the past month, in contrast to the Zacks S&P 500 composite's +10.5% move. With a Zacks Rank #4 (Sell), COR is expected underperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Seeking Clues to Cencora (COR) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
Wall Street analysts expect Cencora (COR - Free Report) to post quarterly earnings of $4.81 per share in its upcoming report, which indicates a year-over-year increase of 8.8%. Revenues are expected to be $80.76 billion, up 7% from the year-ago quarter.
The consensus EPS estimate for the quarter has been revised 0.3% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
That said, let's delve into the average estimates of some Cencora metrics that Wall Street analysts commonly model and monitor.
Analysts expect 'Revenue- Total U.S. Healthcare Solutions' to come in at $71.73 billion. The estimate suggests a change of +5.1% year over year.
Analysts predict that the 'Revenue- Total International Healthcare Solutions' will reach $7.25 billion. The estimate suggests a change of +1.1% year over year.
Analysts forecast 'Operating income- International Healthcare Solutions' to reach $171.94 million. The estimate compares to the year-ago value of $159.30 million.
The combined assessment of analysts suggests that 'Operating income- U.S. Healthcare Solutions' will likely reach $1.04 billion. Compared to the current estimate, the company reported $1.03 billion in the same quarter of the previous year.
View all Key Company Metrics for Cencora here>>>Cencora shares have witnessed a change of -5.2% in the past month, in contrast to the Zacks S&P 500 composite's +10.5% move. With a Zacks Rank #4 (Sell), COR is expected underperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .